Immunity and Disease Prevention Research Unit Site Logo
ARS Home About Us Helptop nav spacerContact Us En Espanoltop nav spacer
Printable VersionPrintable Version     E-mail this pageE-mail this page
Agricultural Research Service United States Department of Agriculture
Search
  Advanced Search
 
Programs and Projects
Subjects of Investigation
 

Research Project: INFLUENCE OF DIETARY FATTY ACIDS ON HUMAN HEALTH WITH EMPHASIS ON IMMUNE AND INFLAMMATORY RESPONSES

Location: Immunity and Disease Prevention Research Unit

Title: Garlic (Allium sativum) Extracts Inhibits Lipopolysaccharide-Induced Toll-Like Receptor 4 Dimerization

Authors
item Youn, Hyung-Sun - SOONCHUNHYANG UNIV.
item Lim, Hyo Jin - SOOKMYUNG WOMENS UNIV.
item Lee, Hwa Jin - SOOKMYUNG WOMENS UNIV.
item Hwang, Daniel
item Yang, Mihi - SOOKMYUNG WOMENS UNIV.
item Jeon, Raok - SOOKMYUNG WOMENS UNIV.
item Ryu, Jae-Ha - SOOKMYUNG WOMENS UNIV.

Submitted to: Bioscience Biotechnology and Biochemistry
Publication Type: Peer Reviewed Journal
Publication Acceptance Date: November 8, 2007
Publication Date: February 7, 2008
Repository URL: http://www.jstage.jst.go.jp/article/bbb/72/2/368/_pdf
Citation: Youn, H., Lim, H., Lee, H., Hwang, D.H., Yang, M., Jeon, R., Ryu, J. 2008. Garlic (Allium sativum) Extracts Inhibits Lipopolysaccharide-Induced Toll-Like Receptor 4 Dimerization. Bioscience Biotechnology and Biochemistry 72(2):368-375, 2008.

Interpretive Summary: Garlic has long been used as a folk medicine. Numerous studies have demonstrated that a garlic extract and its sulfur-containing compounds inhibited nuclear factor kappa B (NF-'B) activation induced by various receptor agonists including lipopolysaccharide (LPS). Toll-like receptors (TLRs) play a key role in sensing diverse microbial products and inducing innate immune responses. The dimerization of TLR4 is required for the activation of downstream signaling pathways, including NF-'B. Therefore, TLR4 dimerization may be one of the first lines of regulation in activating LPS-induced signaling pathways. We report here biochemical evidence that the ethyl acetate fraction of garlic inhibited the LPS-induced dimerization of TLR4, resulting in the inhibition of NF-'B activation and the expression of cyclooxygenase 2 and inducible nitric oxide synthase. Our results demonstrate for the first time that a garlic extract can directly inhibit the TLRs-mediated signaling pathway at the receptor level. These results shed a new insight into understanding how garlic modulates the immune responses that could modify the risk of many chronic diseases.

Technical Abstract: Garlic has been used as a folk medicine for a long history. Numerous studies demonstrated that garlic extracts and its sulfur-containing compounds inhibit nuclear factor-kappa B (NF-kB) activation induced by various receptor agonist including lipopolysaccharide (LPS). These effects suggest that garlic extracts have anti-cancer and anti-inflammatory effects. However, the mechanism as to how garlic extracts mediate the health effects is largely unknown. Toll-like receptors (TLRs) play a key role in sensing diverse microbial products and inducing innate immune responses. The LPS-induced dimerization of TLR4 is required for the activation of NF-kB that is the central mediator of the immune responses. Therefore, TLR4 dimerization may be one of the first lines of regulation in activating LPS-induced signaling pathways. Here, we report biochemical evidence that ethyl acetate fraction of garlic inhibits the LPS-induced dimerization of TLR4 resulting in the inhibition of NF-kB activation and expression of cyclooxygenase 2 and inducible nitric oxide synthase. Our results first demonstrate that garlic extracts can directly inhibit TLRs-mediated signaling pathway at the receptor level. These results shed a new insight in understanding how garlic modulates the immune responses that could modify the risk of many diseases.

   

 
Project Team
Hwang, Daniel
Kelley, Darshan
 
Publications
   Publications
 
Related National Programs
  Human Nutrition (107)
 
 
Last Modified: 05/22/2013
ARS Home | USDA.gov | Site Map | Policies and Links 
FOIA | Accessibility Statement | Privacy Policy | Nondiscrimination Statement | Information Quality | USA.gov | White House